Mara Bloom, JD, MS, Executive Director, Massachusetts General Cancer Center
Overview
Emerging research and technologies are rapidly changing the pace of oncology discovery, innovation and treatment – which in turn is transforming the business models of cancer care. Traditionally, infusion treatments brought patients into hospitals for oncology care but in recent years, treatments have been shifting to oral therapy administered at home. In contrast, novel therapies like immunotherapy and CAR-T must be delivered in a specialized care environment. As a result, leaders like Mara Bloom, JD, MS, Executive Director of the Massachusetts General Hospital Cancer Center, must anticipate therapeutic trends in order to manage and deliver the best care.
In this webinar, Mara Bloom presented the cancer center as a case study for how we can use service-line management to engage stakeholders and streamline healthcare delivery, reduce costs, improve patient experience and encourage continued innovation and growth. Bloom also highlights how the latest therapies, technologies and care models, including home hospital, telemedicine and artificial intelligence will help shape the cancer center of the future.
About the Presenter
Mara Bloom, JD, MS, has been executive director of the Mass General Cancer Center since 2009. In this role, she oversees clinical and research operations at all Cancer Center facilities, including the main campus and all satellite and affiliate sites. Working closely with leadership across the myriad research and clinical disease centers and programs of the Cancer Center, Bloom is guiding development of its strategic direction. Building upon the Cancer Center’s unique assets — including a multidisciplinary model that incorporates the latest therapies and technologies and a collaborative culture among physicians and scientists — she is helping her colleagues evolve Cancer Center operations to advance next-generation paradigms of cancer care.